Search research articles
Contact Us
Filters
Showing results (111-120 of 353) with videos related to
Page
of 36
Sort By:
Journal of Medical Economics
|
January 30, 2025
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes
Phil McEwan, Martin Bøg, Mads Faurby, et al.
Diabetes, Obesity & Metabolism
|
May 9, 2025
Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials
Yu Mi Kang, Erin A Bohula, A Michael Lincoff, et al.
JACC. Advances
|
September 27, 2025
Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid: Clinical Insights From CLEAR Outcomes
Kausik K Ray, Stephen J Nicholls, A Michael Lincoff, et al.
Journal of the American Heart Association
|
June 8, 2017
Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery
Grant W Reed, Samuel Horr, Laura Young, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward
Zubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The American Journal of Cardiology
|
October 26, 2002
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)
M Ashequl Islam, James C Blankenship, Craig Balog, et al.
Journal of Clinical Lipidology
|
November 11, 2023
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance
Harold E Bays, LeAnne T Bloedon, Grace Lin, et al.
Journal of the American College of Cardiology
|
November 20, 2024
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
Subodh Verma, Scott Emerson, Jorge Plutzky, et al.
The American Journal of Cardiology
|
December 3, 2014
Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
Vijay Kunadian, Roxana Mehran, A Michael Lincoff, et al.
Journal of the American Heart Association
|
February 8, 2025
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
Harold E Bays, LeAnne Bloedon, Danielle Brennan, et al.
Page
of 36
Search research articles
Search
Showing results (111-120 of 353) with videos related to
Sort By:
Page
of 36
Journal of Medical Economics
|
January 30, 2025
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes
Phil McEwan, Martin Bøg, Mads Faurby, et al.
Diabetes, Obesity & Metabolism
|
May 9, 2025
Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials
Yu Mi Kang, Erin A Bohula, A Michael Lincoff, et al.
JACC. Advances
|
September 27, 2025
Association of Uric Acid-Lowering Therapies on Gout Frequency with Bempedoic Acid: Clinical Insights From CLEAR Outcomes
Kausik K Ray, Stephen J Nicholls, A Michael Lincoff, et al.
Journal of the American Heart Association
|
June 8, 2017
Associations Between Cardiac Troponin, Mechanism of Myocardial Injury, and Long-Term Mortality After Noncardiac Vascular Surgery
Grant W Reed, Samuel Horr, Laura Young, et al.
Circulation. Cardiovascular Quality and Outcomes
|
July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward
Zubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The American Journal of Cardiology
|
October 26, 2002
Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT)
M Ashequl Islam, James C Blankenship, Craig Balog, et al.
Journal of Clinical Lipidology
|
November 11, 2023
Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance
Harold E Bays, LeAnne T Bloedon, Grace Lin, et al.
Journal of the American College of Cardiology
|
November 20, 2024
Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
Subodh Verma, Scott Emerson, Jorge Plutzky, et al.
The American Journal of Cardiology
|
December 3, 2014
Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
Vijay Kunadian, Roxana Mehran, A Michael Lincoff, et al.
Journal of the American Heart Association
|
February 8, 2025
Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
Harold E Bays, LeAnne Bloedon, Danielle Brennan, et al.
Page
of 36